Screening of differentially expressed genes in 5-fluorouracil-resistant human gastrointestinal tumor cells
- PMID: 11429060
- PMCID: PMC5926762
- DOI: 10.1111/j.1349-7006.2001.tb01150.x
Screening of differentially expressed genes in 5-fluorouracil-resistant human gastrointestinal tumor cells
Abstract
To identify genes differentially expressed in association with resistance to 5-fluorouracil (5FU), an mRNA differential display (DD) analysis was used to compare transcripts from the NUGC-3 human gastric tumor cell line and the NUGC-3 / 5FU / L line, which had acquired 208-fold resistance as a consequence of repeated exposure to escalating concentrations of 5FU. The 110 cDNA fragments differentially expressed in the DD analysis of either the NUGC-3 or NUGC-3 / 5FU / L cells were sequenced and subjected to a homology search, and 29 overexpressed and 22 underexpressed genes were identified in NUGC-3 / 5FU / L as a result. To confirm whether the changes in the gene expression levels in the NUGC-3 / 5FU / L cells were shared by other 5FU-resistant cells, 35 genes were analyzed by northern hybridization in 3 pairs of parent / 5FU-resistant human gastrointestinal tumor cell lines. The analysis revealed 20 overexpressed and 10 underexpressed genes in at least one of the three 5FU-resistant cells as compared with those in the parent cells. Among them, P-glycoprotein, equilibrative nucleoside transporter 1, and methylenetetrahydrofolate dehydrogenase were highly expressed in two of the three 5FU-resistant cells and cytidine deaminase and integrin alpha3 were underexpressed. The acquisition of resistance to 5FU by tumor cells may result from multiple changes in cellular functions.
Similar articles
-
Reduced activity of anabolizing enzymes in 5-fluorouracil-resistant human stomach cancer cells.Jpn J Cancer Res. 1996 Feb;87(2):212-20. doi: 10.1111/j.1349-7006.1996.tb03161.x. Jpn J Cancer Res. 1996. PMID: 8609072 Free PMC article.
-
Prediction of chemosensitivity of colorectal cancer to 5-fluorouracil by gene expression profiling with cDNA microarrays.Int J Oncol. 2005 Aug;27(2):371-6. Int J Oncol. 2005. PMID: 16010417
-
Circumvention of 5-fluorouracil resistance in human stomach cancer cells by uracil phosphoribosyltransferase gene transduction.Jpn J Cancer Res. 1999 Mar;90(3):349-54. doi: 10.1111/j.1349-7006.1999.tb00754.x. Jpn J Cancer Res. 1999. PMID: 10359051 Free PMC article.
-
Establishment and characterization of monoclonal 5-fluorouracil-resistant cell lines derived from human endometrial adenocarcinoma.Int J Oncol. 2010 Sep;37(3):731-6. doi: 10.3892/ijo_00000722. Int J Oncol. 2010. PMID: 20664942
-
Impaired death-associated protein kinase-mediated survival signals in 5-fluorouracil-resistant human endometrial adenocarcinoma cells.Oncol Rep. 2012 Jul;28(1):330-6. doi: 10.3892/or.2012.1774. Epub 2012 Apr 23. Oncol Rep. 2012. PMID: 22552543
Cited by
-
Molecular Bases of Mechanisms Accounting for Drug Resistance in Gastric Adenocarcinoma.Cancers (Basel). 2020 Jul 30;12(8):2116. doi: 10.3390/cancers12082116. Cancers (Basel). 2020. PMID: 32751679 Free PMC article. Review.
-
Clinical significance of UGT1A1 polymorphism and expression of ERCC1, BRCA1, TYMS, RRM1, TUBB3, STMN1 and TOP2A in gastric cancer.BMC Gastroenterol. 2017 Jan 5;17(1):2. doi: 10.1186/s12876-016-0561-x. BMC Gastroenterol. 2017. PMID: 28056823 Free PMC article.
-
Enhancement of 5-fluorouracil-induced cytotoxicity by leucovorin in 5-fluorouracil-resistant gastric cancer cells with upregulated expression of thymidylate synthase.Gastric Cancer. 2014 Jan;17(1):188-95. doi: 10.1007/s10120-013-0249-7. Epub 2013 Mar 15. Gastric Cancer. 2014. PMID: 23494117 Free PMC article.
-
Gene expression in colorectal cancer and in vitro chemosensitivity to 5-fluorouracil: a study of 88 surgical specimens.Cancer Sci. 2003 Jul;94(7):633-8. doi: 10.1111/j.1349-7006.2003.tb01495.x. Cancer Sci. 2003. PMID: 12841874 Free PMC article.
-
Genome-wide screening of loci associated with drug resistance to 5-fluorouracil-based drugs.Cancer Sci. 2007 Apr;98(4):577-83. doi: 10.1111/j.1349-7006.2007.00424.x. Cancer Sci. 2007. PMID: 17425594 Free PMC article.
References
-
- Mader , R. M. , Müller , M. and Steger , G. G.Resistance to 5‐fluorouracil . Gen. Pharmacol. , 31 , 661 – 666 ( 1998. ). - PubMed
-
- Johnston , P. G. , Drake , J. C. , Trepel , J. and Allegra , C. J.Immunological quantitation of thymidylate synthase using the monoclonal antibody TS 106 in 5‐fluorouracil‐sensitive and ‐resistant human cancer cell lines . Cancer Res. , 52 , 4306 – 4312 ( 1992. ). - PubMed
-
- Aschele , C. , Sobrero , A. , Faderan , M. A. and Bertino , J. R.Novel mechanism(s) of resistance to 5‐fluorouracil in human colon cancer (HCT‐8) sublines following exposure to two different clinically relevant dose schedules . Cancer Res. , 52 , 1855 – 1864 ( 1992. ). - PubMed
-
- Copur , S. , Aiba , K. , Drake , J. C. , Allegra , C. J. and Chu , E.Thymidylate synthase gene amplification in human colon cancer cell lines resistant to 5‐fluorouracil . Biochem. Pharmacol. , 49 , 1419 – 1426 ( 1995. ). - PubMed
-
- Chu , E. , Lai , G. M. , Zinn , S. and Allegra , C. J.Resistance of a human ovarian cancer line to 5‐fluorouracil associated with decreased levels of 5‐fluorouracil in DNA . Mol. Pharmacol. , 38 , 410 – 417 ( 1990. ). - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources